Sign in Subscribe
Epidemics

$10 Billion Covid Aid Package Announced, But Fails to Include Global Vaccination Funding

Strategic Insights

— 1 min read

The bipartisan $10 billion coronavirus aid package announced by Senate leaders on Monday does not include funds for the global vaccination effort, drawing criticism from some Democrats. The package, which provides additional aid for domestic testing, vaccination, and treatment efforts, requires at least $5 billion for therapeutics and $750 million for research and clinical trials to prepare for future variants. The remaining funds will be used for vaccines and testing. The agreement was announced by Senate Majority Leader Chuck Schumer and Republican Senator Mitt Romney, who have led negotiations in recent days.

Key Takeaways:

  • The $10 billion aid package does not include $5 billion in funding for the global vaccination effort that had previously been proposed.
  • The agreement requires at least $5 billion to be set aside for therapeutics and $750 million for research and clinical trials to prepare for future variants.
  • The package was announced by Senators Chuck Schumer and Mitt Romney, who have led negotiations in recent days.
  • Democrats have expressed frustration with the omission of the global vaccination aid, which is central to President Biden's strategy of reducing vaccine inequality and limiting the impact of the next coronavirus variant.
  • Several Democrats have said the urgent need to provide domestic aid warrants their support, but they will push for a robust international funding bill in the coming weeks.
  • Recent efforts to pass an initial $15.6 billion Covid package collapsed last month when House Democrats balked at clawing back money that had been set aside for state governments in last year's law.
  • The measure includes a bipartisan bill that will give state, local, and tribal governments more flexibility in how coronavirus aid is spent.

Statistics:

  • $10 billion: The amount of the aid package.
  • $5 billion: The amount set aside for therapeutics.
  • $750 million: The amount for research and clinical trials to prepare for future variants.
  • 15%: The percentage of the population in low-income countries that has received at least one vaccine dose.
  • 80%: The percentage of the population in middle- and high-income countries that has received at least one vaccine dose.

Sources:

  • The New York Times: "Senate Leaders Announce $10 Billion Covid Aid Package, Excluding Global Vaccination Funding"
  • Our World in Data project at the University of Oxford: "COVID-19 Vaccination"

Read more